Hotline:
+49 (0) 34291 / 33 72 36
contact@hpc-standards.com

US Shop

New user? / Forgot your password?

0 Item | 0,00 €

Need NMR solvents or supplies? Click here and check out our ARMAR Isotopes catalog!

 

  • Package Size
  •   1 Unit
  •   2 Units
  •   3 Units
  •   4 Units
  •   7 Units
  •   8 Units
  •   11 Units
  •   100 Units
  •   600 Units
  • Volume
  •   1 mg
  •   2 mg
  •   2.5 mg
  •   2.61 mg
  •   5 mg
  •   10 mg
  •   20 mg
  •   25 mg
  •   50 mg
  •   100 mg
  •   200 mg
  •   250 mg
  •   261 mg
  •   500 mg
  •   1000 mg
  •   5000 mg
  •   0.5 ml
  •   1 ml
  •   5 ml
  •   10 ml
  •   100 ml
  •   500 ml
  •   0.18 g
  •   0.2 g
  •   0.25 g
  •   0.3 g
  •   0.35 g
  •   0.4 g
  •   0.5 g
  •   0.53 g
  •   0.6 g
  •   0.7 g
  •   0.73 g
  •   0.8 g
  •   0.83 g
  •   1 g
  •   1.05 g
  •   1.07 g
  •   1.1 g
  •   1.2 g
  •   1.3 g
  •   1.6 g
  •   2 g
  •   5 g
  •   6.5 g
  •   7.5 g
  •   250 g
  •   100 pcs

 

Omethoate

Item number675430
CAS1113-02-6
FormulaC5H12NO4PS
Molecular weight213,19 g/mol
Quantity 1X100MG
storage conditions4 °C
CoA / MSDSRetrieve CoA
Retrieve MSDS
Omethoate

Price

Please log in.

Part of Product groups:

 

 

Product Variations:

Product

Catalog No./ CAS No.

Quantity

Price

D6-Omethoate solution
Concentration: 100 µg/ml
Solvent: Acetone

D6-Omethoate solution

680026
1219804-92-8

1X1ML

Please log in.

Omethoate solution
Concentration: 100 µg/ml
Solvent: Acetonitrile

Omethoate solution

673399
1113-02-6

1X5ML

Please log in.

Omethoate

Omethoate

675430
1113-02-6

1X100MG

Please log in.

Safety Data Sheetaccording to Regulation (EC) No 1907/2006 (REACH)
Classifications according to Regulation (EC) No 1272/2008.
Printdate 04.12.2024
IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING
Product name:Omethoate
Catalog No.:675430
Relevant identified uses of the substance or mixtureIdentified: Laboratory chemical
uses: R&D
Uses advised against:HPC Standards GmbH
Am Wieseneck 7

04451 Cunnersdorf
Deutschland


Tel. +49 34291 3372-36
Fax. +49 34291 3372-39
contact@hpc-standards.com
Emergency telephone numberHPC Standards Tel. +49 34291 3372-36
This number is only available during office hours.
HAZARDS IDENTIFICATION2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Oral (Category 2)
Acute toxicity, Dermal (Category 3)
Acute aquatic toxicity (Category 1)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Toxic if swallowed. Harmful in contact with skin. Very toxic to aquatic organisms
Label elements
PictogramGHS06 skull
skull
GHS09 Aquatic-pollut-red
Aquatic-pollut-red
Signal word Danger
Hazard statement(s)
H300 Fatal if swallowed.
H311 Toxic in contact with skin.
H400 Very toxic to aquatic life.
Precautionary statement(s)
P264 Wash hands thoroughly after handling.
P273 Avoid release to the environment.
P280 Wear protective gloves/ protective clothing.
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/
physician.
P312 Call a POISON CENTER or doctor/ physician if you feel unwell Supplemental Hazard
Statements
none
According to European Directive 67/548/EEC as amended.
Hazard symbol(s) R-phrase(s)
R21 Harmful in contact with skin.
R25 Toxic if swallowed.
R50 Very toxic to aquatic organisms.
S-phrase(s)
S23 Do not breathe gas/fumes/vapour/spray.
S36/37 Wear suitable protective clothing and gloves.
S45 In case of accident or if you feel unwell, seek medical advice immediately
(show the label where possible).
S61 Avoid release to the environment. Refer to special instructions/ Safety
data sheets.
2.3 Other hazards - none
COMPOSITION/INFORMATION ON INGREDIENTS3.1 Substances
Formula : C5H12NO4PS
Molecular Weight : 213,19 g/mol
Component Concentration
Omethoate
CAS-No.
EC-No.
Index-No.
1113-02-6
214-197-8
015-066-00-6
-
FormulaC5H12NO4PS
Molecular Weight (g/mol)213.19
CAS-No.1113-02-6
FIRST AID MEASURES4.1 Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Take victim immediately to hospital. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
4.2 Most important symptoms and effects, both acute and delayed
Cholinesterase inhibitors can cause heavy salivation and secretion in the lungs, lachrymation, blurred
vision, involuntary defecation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate, and/or a
fall in blood pressure as a result of their action at cholinergic nerve sites., Headache, Nausea, Vomiting,
Dizziness, Drowsiness, Confusion., Weakness, Muscle cramps/spasms., Change in pupil size., Fever,
Seizures., Incoordination., Convulsions, Coma.
4.3 Indication of any immediate medical attention and special treatment needed
no data available
FIRE-FIGHTING MEASURES5.1 Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
5.2 Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Sulphur oxides, Oxides of phosphorus
5.3 Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
5.4 Further information
no data available
ACCIDENTAL RELEASE MEASURES6.1 Personal precautions, protective equipment and emergency procedures
Wear respiratory protection. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate
personnel to safe areas.
6.2 Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
6.3 Methods and materials for containment and cleaning up
Soak up with inert absorbent material and dispose of as hazardous waste. Keep in suitable, closed
containers for disposal.
6.4 Reference to other sections
For disposal see section 13.
HANDLING AND STORAGE7.1 Precautions for safe handling
Avoid contact with skin and eyes. Avoid inhalation of vapour or mist.
7.2 Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Containers which are
opened must be carefully resealed and kept upright to prevent leakage.
Recommended storage temperature: 2 - 8 °C
7.3 Specific end uses
no data available
EXPOSURE CONTROLS/PERSONAL PROTECTION8.1 Control parameters
Components with workplace control parameters
8.2 Exposure controls
Appropriate engineering controls
Avoid contact with skin, eyes and clothing. Wash hands before breaks and immediately after handling
the product.
Personal protective equipment
Eye/face protection
Face shield and safety glasses Use equipment for eye protection tested and approved under
appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands. Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face respirator
with multi-purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a backup
to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air
respirator. Use respirators and components tested and approved under appropriate government
standards such as NIOSH (US) or CEN (EU).
PHYSICAL AND CHEMICAL PROPERTIES9.1 Information on basic physical and chemical properties
a) Appearance Form: liquid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing
point
no data available
f) Initial boiling point and
boiling range
no data available
g) Flash point 100 °C - closed cup
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower
flammability or
explosive limits
no data available
k) Vapour pressure 4,3 hPa at 20 °C
l) Vapour density no data available
m) Relative density 1,320 g/cm3
n) Water solubility soluble
o) Partition coefficient: noctanol/
water
no data available
p) Autoignition
temperature
no data available
q) Decomposition
temperature
no data available
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
9.2 Other safety information
no data available
STABILITY AND REACTIVITY10.1 Reactivity
no data available
10.2 Chemical stability
no data available
10.3 Possibility of hazardous reactions
no data available
10.4 Conditions to avoid
no data available
10.5 Incompatible materials
Bases
10.6 Hazardous decomposition products
Other decomposition products - no data available
TOXICOLOGICAL INFORMATION11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - rat - 30 mg/kg
LD50 Inhalation - mouse - 4 h - 140 mg/m3
Remarks: Biochemical:Enzyme inhibition, induction, or change in blood or tissue levelsTrue
cholinesterase.
LC50 Inhalation - rat - 1 h - > 1.500 mg/m3
LD50 Dermal - rat - 700 mg/kg
LD50 Intraperitoneal - rat - 14,400 mg/kg
Remarks: Biochemical:Enzyme inhibition, induction, or change in blood or tissue levelsTrue
cholinesterase.
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
Genotoxicity in vitro - Human - lymphocyte
Sister chromatid exchange
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available Aspiration hazard
no data available
Potential health effects Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be fatal if swallowed.
Skin Toxic if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
Cholinesterase inhibitors can cause heavy salivation and secretion in the lungs, lachrymation, blurred
vision, involuntary defecation, diarrhea, tremor, ataxia, sweating, hypothermia, lowered heart rate, and/or a
fall in blood pressure as a result of their action at cholinergic nerve sites., Headache, Nausea, Vomiting,
Dizziness, Drowsiness, Confusion., Weakness, Muscle cramps/spasms., Change in pupil size., Fever,
Seizures., Incoordination., Convulsions, Coma.
Additional Information
RTECS: TF8050000
ECOLOGICAL INFORMATION12.1 Toxicity
Toxicity to fish LC50 - Poecilia reticulata (guppy) - 48 mg/l - 96,0 h
Toxicity to daphnia and
other aquatic
invertebrates
EC50 - Daphnia magna (Water flea) - 0,021 mg/l - 48 h
12.2 Persistence and degradability
no data available
12.3 Bioaccumulative potential
no data available
12.4 Mobility in soil
no data available
12.5 Results of PBT and vPvB assessment
no data available
12.6 Other adverse effects
Very toxic to aquatic life.
DISPOSAL CONSIDERATIONS13.1 Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.
TRANSPORT INFORMATION14.1 UN number
ADR/RID: 2810 IMDG: 2810 IATA: 2810
14.2 UN proper shipping name
ADR/RID: TOXIC LIQUID, ORGANIC, N.O.S. (Omethoate)
IMDG: TOXIC LIQUID, ORGANIC, N.O.S. (Omethoate)
IATA: Toxic liquid, organic, n.o.s. (Omethoate)
14.3 Transport hazard class(es)
ADR/RID: 6.1 IMDG: 6.1 IATA: 6.1
14.4 Packaging group
ADR/RID: II IMDG: II IATA: II
14.5 Environmental hazards
ADR/RID: yes IMDG Marine pollutant: yes IATA: no 14.6 Special precautions for user
no data available
REGULATORY INFORMATIONThis safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
15.2 Chemical Safety Assessment
no data available
OTHER INFORMATIONThe above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. For lab use only!